Apremilast Modified-Release Tablets(Taizhou Overseas Pharma)
阿普斯特多释片（越洋医药）
Report date: 2025/08/19 14:36:08
First In Class
Base Information
Drug NameApremilast Modified-Release Tablets(Taizhou Overseas Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A